BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28535976)

  • 1. Organic Anion-Transporting Polypeptide and Efflux Transporter-Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans.
    Wang C; Huo X; Wang C; Meng Q; Liu Z; Sun P; Cang J; Sun H; Liu K
    J Pharm Sci; 2017 Sep; 106(9):2515-2523. PubMed ID: 28535976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
    Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
    Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
    Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1/1B3.
    Dong J; Olaleye OE; Jiang R; Li J; Lu C; Du F; Xu F; Yang J; Wang F; Jia W; Li C
    Br J Pharmacol; 2018 Sep; 175(17):3486-3503. PubMed ID: 29908072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
    Alam K; Farasyn T; Crowe A; Ding K; Yue W
    PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
    Sheng J; Tian X; Xu G; Wu Z; Chen C; Wang L; Pan L; Huang C; Pan G
    Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker.
    Nakagomi-Hagihara R; Nakai D; Kawai K; Yoshigae Y; Tokui T; Abe T; Ikeda T
    Drug Metab Dispos; 2006 May; 34(5):862-9. PubMed ID: 16501004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling.
    Mitra P; Weinheimer S; Michalewicz M; Taub ME
    Drug Metab Dispos; 2018 Jul; 46(7):953-963. PubMed ID: 29666154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OATP and MRP2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human.
    Sun P; Wang C; Liu Q; Meng Q; Zhang A; Huo X; Sun H; Liu K
    Pharmacol Rep; 2014 Apr; 66(2):311-9. PubMed ID: 24911086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
    Kunze A; Huwyler J; Camenisch G; Poller B
    Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Rat Sandwich-Cultured Hepatocytes Model Expressing Functional Human Organic Anion Transporting Polypeptide (OATP) 1B3: A Potential Screening Tool for Liver-Targeting Compounds.
    Farasyn T; Xu C; Yue W
    J Pharm Pharm Sci; 2021; 24():475-483. PubMed ID: 34516949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3.
    Chen Y; Chen L; Zhang H; Huang S; Xiong Y; Xia C
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):147-154. PubMed ID: 29498478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.
    Takanohashi T; Kubo S; Arisaka H; Shinkai K; Ubukata K
    J Pharm Pharmacol; 2012 Feb; 64(2):199-206. PubMed ID: 22221095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.
    Farasyn T; Crowe A; Hatley O; Neuhoff S; Alam K; Kanyo J; Lam TT; Ding K; Yue W
    J Pharm Sci; 2019 Oct; 108(10):3443-3456. PubMed ID: 31047942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Uptake Mechanism of Ophiopogonin D Mediated by Organic Anion Transporting Polypeptides.
    Zhang W; Xiong X; Chen L; Liu M; Xiong Y; Zhang H; Huang S; Xia C
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):669-676. PubMed ID: 27815731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.
    De Bruyn T; Fattah S; Stieger B; Augustijns P; Annaert P
    J Pharm Sci; 2011 Nov; 100(11):5018-30. PubMed ID: 21837650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist).
    Sandoval P; Chuang BC; Fallon JK; Smith PC; Chowdhury SK; Griffin RJ; Xia CQ; Iwasaki S; Chothe PP
    AAPS J; 2022 Sep; 24(6):99. PubMed ID: 36123502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
    Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
    Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
    Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
    Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.